A detailed history of Kornitzer Capital Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Kornitzer Capital Management Inc holds 1,168,315 shares of PFE stock, worth $30.2 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
1,168,315
Previous 1,140,753 2.42%
Holding current value
$30.2 Million
Previous $31.9 Million 5.93%
% of portfolio
0.65%
Previous 0.63%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$27.7 - $31.39 $763,467 - $865,171
27,562 Added 2.42%
1,168,315 $33.8 Million
Q2 2024

Aug 02, 2024

SELL
$25.26 - $29.6 $1.31 Million - $1.54 Million
-51,962 Reduced 4.36%
1,140,753 $31.9 Million
Q1 2024

May 01, 2024

BUY
$25.89 - $29.73 $218,951 - $251,426
8,457 Added 0.71%
1,192,715 $33.1 Million
Q4 2023

Jan 31, 2024

BUY
$26.13 - $33.94 $15,338 - $19,922
587 Added 0.05%
1,184,258 $34.1 Million
Q3 2023

Oct 31, 2023

BUY
$32.09 - $37.51 $418,581 - $489,280
13,044 Added 1.11%
1,183,671 $39.3 Million
Q2 2023

Aug 01, 2023

BUY
$36.12 - $41.79 $734,897 - $850,259
20,346 Added 1.77%
1,170,627 $42.9 Million
Q1 2023

May 09, 2023

BUY
$39.39 - $51.28 $482,685 - $628,385
12,254 Added 1.08%
1,150,281 $46.9 Million
Q4 2022

Feb 02, 2023

SELL
$41.75 - $54.5 $79,533 - $103,822
-1,905 Reduced 0.17%
1,138,027 $58.3 Million
Q3 2022

Nov 03, 2022

SELL
$43.76 - $53.42 $808,816 - $987,361
-18,483 Reduced 1.6%
1,139,932 $49.9 Million
Q2 2022

Aug 03, 2022

SELL
$46.53 - $55.17 $149,826 - $177,647
-3,220 Reduced 0.28%
1,158,415 $60.7 Million
Q1 2022

Apr 27, 2022

SELL
$45.75 - $56.69 $1.77 Million - $2.19 Million
-38,648 Reduced 3.22%
1,161,635 $60.1 Million
Q4 2021

Feb 01, 2022

SELL
$41.32 - $61.25 $455,966 - $675,893
-11,035 Reduced 0.91%
1,200,283 $70.9 Million
Q3 2021

Nov 03, 2021

SELL
$39.25 - $50.42 $73,358 - $94,234
-1,869 Reduced 0.15%
1,211,318 $52.1 Million
Q2 2021

Jul 30, 2021

BUY
$35.91 - $40.68 $29,518 - $33,438
822 Added 0.07%
1,213,187 $47.5 Million
Q1 2021

Apr 30, 2021

BUY
$33.49 - $37.77 $480,380 - $541,772
14,344 Added 1.2%
1,212,365 $43.9 Million
Q4 2020

Jan 29, 2021

SELL
$33.47 - $42.56 $264,915 - $336,862
-7,915 Reduced 0.66%
1,198,021 $44.1 Million
Q3 2020

Oct 30, 2020

SELL
$31.75 - $37.25 $55,245 - $64,815
-1,740 Reduced 0.14%
1,205,936 $44.3 Million
Q2 2020

Aug 03, 2020

BUY
$30.12 - $36.54 $1.09 Million - $1.32 Million
36,148 Added 3.09%
1,207,676 $39.5 Million
Q1 2020

Apr 30, 2020

SELL
$27.03 - $38.62 $50,194 - $71,717
-1,857 Reduced 0.16%
1,171,528 $38.2 Million
Q4 2019

Jan 31, 2020

SELL
$32.92 - $37.36 $465,719 - $528,531
-14,147 Reduced 1.19%
1,173,385 $46 Million
Q3 2019

Nov 04, 2019

SELL
$32.49 - $42.13 $452,260 - $586,449
-13,920 Reduced 1.16%
1,187,532 $42.7 Million
Q2 2019

Jul 31, 2019

SELL
$36.98 - $41.52 $48,813 - $54,806
-1,320 Reduced 0.11%
1,201,452 $52 Million
Q1 2019

May 01, 2019

BUY
$37.5 - $41.2 $81,150 - $89,156
2,164 Added 0.18%
1,202,772 $51.1 Million
Q4 2018

Jan 31, 2019

SELL
$38.47 - $43.86 $507,188 - $578,250
-13,184 Reduced 1.09%
1,200,608 $52.4 Million
Q3 2018

Nov 13, 2018

SELL
$34.47 - $41.81 $247,494 - $300,195
-7,180 Reduced 0.59%
1,213,792 $53.5 Million
Q2 2018

Aug 02, 2018

SELL
$32.98 - $35.16 $24,734 - $26,369
-750 Reduced 0.06%
1,220,972 $44.3 Million
Q1 2018

Apr 30, 2018

BUY
$31.91 - $37.02 $1.05 Million - $1.22 Million
33,015 Added 2.78%
1,221,722 $43.4 Million
Q4 2017

Jan 31, 2018

SELL
$33.26 - $35.29 $225,170 - $238,913
-6,770 Reduced 0.57%
1,188,707 $43.1 Million
Q3 2017

Oct 31, 2017

BUY
$31.0 - $34.15 $37.1 Million - $40.8 Million
1,195,477
1,195,477 $42.7 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Kornitzer Capital Management Inc Portfolio

Follow Kornitzer Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Kornitzer Capital Management Inc with notifications on news.